Eisai

4523.TPharmaceutical

Key numbers · FY ended 2026-03

Revenue¥825.4bn+4.6% YoY Operating income¥44.1bn-18.8% YoY Net income (owners)¥38.6bn-17.0% YoY Total assets¥1.45T+4.5% YoY EPS (basic)¥136.78-16.5% YoY

Full financial history and reports →

Stock price4523 · View chart ↗

Open the price chart on TradingView.

Latest filings

Fri, Oct 2 · JST1 filing

15:35MATERIALEisai · Event with a material impact on financial position

Wed, Mar 12 · JST1 filing

15:06MATERIALEisai · Change of representative director

All filings →

Major holders (5%+) · 1

Holder	Stake	Change	Filed
Nomura Asset Management Co., Ltd.	7.29%	—	2026-07-06

Each holder's own ratio from its most recent large-shareholding report.